This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (39)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Thrombolysis  • Cardiovascular Disease/ Myocardial Infarction  • Adverse Effects  • Alert me on articles by topic

Khaled Buresly, BMChB, FRCPC; Mark J. Eisenberg, MD, MPH; Xun Zhang, MSc, PhD; Louise Pilote, MD, MPH, PhD

Arch Intern Med. 2005;165:784-789.

Background  Combinations of aspirin with thienopyridine derivatives (clopidogrel bisulfate or ticlopidine hydrochloride) and/or warfarin sodium are increasingly being used in various cardiac conditions. However, little is known about the bleeding risks associated with these combinations, particularly in elderly individuals at the population level. This study estimates the bleeding risks associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients.

Methods  We conducted a population-based observational cohort study using linked administrative databases. A total of 21 443 elderly survivors of acute myocardial infarction between 1996 and 2000 were studied. Patients were divided into 5 groups according to drug exposure: aspirin alone, warfarin alone, aspirin plus a thienopyridine derivative (antiplatelet combination), aspirin plus warfarin (anticoagulant combination), and aspirin plus warfarin plus a thienopyridine derivative (3-drug combination). Hospitalizations for bleeding events were examined.

Results  Hospitalizations for bleeding were observed in 1428 patients (7%). Compared with rates of patients receiving aspirin alone (0.03 per patient-year), rates of bleeding were higher among patients receiving the antiplatelet combination (0.07 per patient-year), the anticoagulant combination (0.08 per patient-year), and the 3-drug combination (0.09 per patient-year). Compared with aspirin alone, the adjusted odds ratios (95% confidence intervals) for bleeding were 1.65 (1.02-2.73) for patients receiving the antiplatelet combination and 1.92 (1.28-2.87) for patients receiving the anticoagulant combination. Only 1 of 141 patients in the 3-drug combination group had a bleeding event.

Conclusion  In practice, antiplatelet and anticoagulant combinations lead to modest increases in bleeding risk in elderly patients, but the overall risk is small.

Author Affiliations: McGill University Health Centre Research Institute and the Jewish General Hospital, Montreal, Quebec.

RELATED LETTER

Bleeding Complications in Elderly Patients Following Acute Myocardial Infarction
Sudeep S. Gill
Arch Intern Med. 2005;165(20):2430-2431.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Managing the anticoagulated patient with atrial fibrillation at high risk of stroke who needs coronary intervention
Lip
BMJ 2008;337:a840-a840.
FULL TEXT  

Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous?
Hermosillo and Spinler
The Annals of Pharmacotherapy 2008;42:790-805.
ABSTRACT | FULL TEXT  

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Schulman et al.
Chest 2008;133:257S-298S.
ABSTRACT | FULL TEXT  

Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Singer et al.
Chest 2008;133:546S-592S.
ABSTRACT | FULL TEXT  

The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Becker et al.
Chest 2008;133:776S-814S.
ABSTRACT | FULL TEXT  

Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study
Toyoda et al.
Stroke 2008;39:1740-1745.
ABSTRACT | FULL TEXT  

Outcomes Associated With Combined Antiplatelet and Anticoagulant Therapy
Johnson et al.
Chest 2008;133:948-954.
ABSTRACT | FULL TEXT  

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Stent Implantation in Patients Taking Chronic Oral Anticoagulation
Rogacka et al.
J Am Coll Cardiol Intv 2008;1:56-61.
ABSTRACT | FULL TEXT  

Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding
Delaney et al.
CMAJ 2007;177:347-351.
ABSTRACT | FULL TEXT  

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT  

Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation
Hylek et al.
Circulation 2007;115:2689-2696.
ABSTRACT | FULL TEXT  

Warfarin and Antiplatelet Combination Use Among Commercially Insured Patients Enrolled in an Anticoagulation Management Service
Johnson et al.
Chest 2007;131:1500-1507.
ABSTRACT | FULL TEXT  

Anticoagulants in heart disease: current status and perspectives
De Caterina et al.
Eur Heart J 2007;0:ehl492v1-34.
FULL TEXT  

The good, the bad, and the ugly: triple therapy after PCI in patients requiring chronic anticoagulation
Sinnaeve
Eur Heart J 2007;28:657-658.
FULL TEXT  

Anticoagulant and Antiplatelet Therapy Use in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: The Need for Consensus and a Management Guideline
Lip and Karpha
Chest 2006;130:1823-1827.
ABSTRACT | FULL TEXT  

The combination of anticoagulant and anti-platelet therapy in patients with atrial fibrillation: a comment on the recent ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: reply
Zamorano and Canadas
Eur Heart J 2006;27:2909-2910.
FULL TEXT  

Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study
Hallas et al.
BMJ 2006;333:726.
ABSTRACT | FULL TEXT  

Drug interactions in the setting of acute coronary syndromes and dual anti-platelet therapy
Bassand
Eur Heart J Suppl 2006;8:G35-G37.
ABSTRACT | FULL TEXT  

Bleeding and management of bleeding
Eikelboom and Hirsh
Eur Heart J Suppl 2006;8:G38-G45.
ABSTRACT | FULL TEXT  

Bleeding Complications in Elderly Patients Following Acute Myocardial Infarction
Gill
Arch Intern Med 2005;165:2430-2431.
FULL TEXT  

Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart et al.
Stroke 2005;36:1588-1593.
ABSTRACT | FULL TEXT  

Bleeding Risk with Combination Therapies in Elderly MI Patients
Journal Watch Cardiology 2005;2005:4-4.
FULL TEXT